Home | Product Development | Corporate Information | Picture Gallery | Careers | Contact Us | Employee Login
 
 
 
  Our Products
  All Products
List of Generics
  Therapeutic Classes
 
CORE BRANDS
 
PRODUCT
Lucast
 
Generic:
Montelukast sodium
 
Therapeutic Class:
Antiasthmatics
 
Composition:

Lucast 4 mg Sachet:
Each sachet contains Montelukast 4 mg (as sodium salt).

Lucast 4 mg Tablets:
Each chewable tablet contains Montelukast 4 mg (as sodium salt).

Lucast 5 mg Tablets:
Each chewable tablet contains Montelukast 5 mg (as sodium salt).

Lucast 10 mg Tablets:
Each tablet contains Montelukast 10 mg (as sodium salt).
 
Description:
Lucast contains montelukast sodium, a relatively new and effective therapy recommended by international and national guidelines for the control (prevention) of acute and chronic asthmatic attacks.
 
Indications:

Asthma:

Lucast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.

Allergic Rhinitis:

Lucast is indicated for the relief of symptoms of:

  • Seasonal allergic rhinitis in patients 2 years of age and older
  • Perennial allergic rhinitis in patients 6 months of age and older.

Exercise-Induced Bronchoconstriction (EIB):

Lucast is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older.

 
Dosage:

Asthma:

Lucast should be taken once daily in the evening. The following doses are recommended:

For adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

For pediatric patients 2 to 5 years of age: One Lucast 4 mg chewable tablet or one Lucast 4 mg sachet.

For pediatric patients 12 to 23 months of age: One Lucast 4 mg sachet.

Safety and effectiveness in pediatric patients less than 12 months of age with asthma have not been established.

Allergic Rhinitis:

For allergic rhinitis, Lucast should be taken once daily.

Seasonal allergic rhinitis

The following doses for the treatment of symptoms of seasonal allergic rhinitis are recommended:

For adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

For pediatric patients 2 to 5 years of age: One Lucast 4 mg chewable tablet or One Lucast 4 mg sachet.

Safety and effectiveness in pediatric patients younger than 2 years of age with seasonal allergic rhinitis have not been established.

Perennial allergic rhinitis

The following doses for the treatment of symptoms of perennial allergic rhinitis are recommended:

For adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

For pediatric patients 2 to 5 years of age: One Lucast 4 mg chewable tablet or One Lucast 4 mg sachet.

For pediatric patients 6 to 23 months of age: One Lucast 4 mg sachet.

Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis have not been established.

Asthma and Allergic Rhinitis:

Patients with both asthma and allergic rhinitis should take only one Lucast dose daily in the evening.

Exercise-Induced Bronchoconstriction (EIB):

For prevention of EIB, a single dose of Lucast should be taken at least 2 hours before exercise. The following doses are recommended:

For adults and adolescents 15 years of age and older: One Lucast 10 mg tablet.

For pediatric patients 6 to 14 years of age: One Lucast 5 mg chewable tablet.

An additional dose of Lucast should not be taken within 24 hours of a previous dose. 

 
Presentations:

10 mg   Tabs 10’s

5   mg   Tabs 10’s

4   mg   Tabs 14’s

4   mg   Sachet 14’s